首页> 外文期刊>Journal of the mechanical behavior of biomedical materials >The mechanical behavior and biocompatibility of polymer blends for Patent Ductus Arteriosus (PDA) occlusion device
【24h】

The mechanical behavior and biocompatibility of polymer blends for Patent Ductus Arteriosus (PDA) occlusion device

机译:动脉导管未闭(PDA)封堵器的聚合物共混物的机械性能和生物相容性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Patent Ductus Arteriosus(PDA) is a cardiovascular defect that occurs in 1 out of every 2000 births, and if left untreated, may lead to severe cardiovascular problems. Current options for occluding utilize meta scaffolds with polymer fabric, and are permanent. The purpose of this study was to develop a fully degradable occluder for the closure of PDA, that can be deployed percutaneously without open-heart surgery. For percutaneous deployment, both elasticity and sufficient mechanical strength are required of the device components. As this combination of properties is not achievable with currently-available homo- or copolymers, blends of biodegradable poly(epsilon-caprolactone) (PCL) and poly(L-lactide-co-epsilon-caprolactone) (PLC) with various compositions were studied as the potential material for the PDA occlusion device. Microstructures of this blend were characterized by differential scanning calorimetry (DSC) and tensile tests. DSC results demonstrated the immiscibility between PCL and its copolymer PLC. Furthermore, the mechanical properties, i.e. elastic modulus and strain recovery, of the blends could be largely tailored by changing the continuous phase component. Based on the thermo-mechanical tests, suitable blends were selected to fabricate a prototype of PDA occluder and its in vitro performance, in term of device recovery (from its sheathed configuration), biodegradation rate and blood compatibility, was evaluated. The current results indicate that the device is able to recover elastically from a sheath within 2-3 min for deployment; the device starts to disintegrate within 5-6 months, and the materials have no adverse effects on the platelet and leucocyte components of the blood. Biocompatibility implantation studies of the device showed acceptable tissue response. Finally, an artificial PDA conduit was created in a pig model, and the device deployment was tested from a sheath: the device recovered within 2-3 min of unsheathing and fully sealed the conduit, the device remains stable and is completely covered by tissue at 1 month follow up. Thus, a novel prototype for PDA occlusion that is fully degradable has been developed to overcome the limitations of the currently used metal/fabric devices. (C) 2014 Elsevier Ltd. All rights reserved.
机译:动脉导管未闭(PDA)是一种心血管缺陷,每2000例新生儿中就有1例发生,如果不加以治疗,可能会导致严重的心血管问题。当前用于阻塞的选择是使用具有聚合物织物的间位支架,并且是永久的。这项研究的目的是开发一种完全可降解的封堵器,用于闭合PDA,无需经开胸手术即可经皮部署。对于经皮展开,装置部件既需要弹性又需要足够的机械强度。由于目前的均聚物或共聚物无法实现这种性能组合,因此研究了具有各种组成的可生物降解的聚(ε-己内酯)(PCL)和聚(L-丙交酯-ε-己内酯)(PLC)的共混物作为PDA闭塞装置的潜在材料。该混合物的微结构通过差示扫描量热法(DSC)和拉伸试验来表征。 DSC结果表明PCL及其共聚物PLC不相容。此外,可以通过改变连续相成分来大幅度地调节共混物的机械性能,即弹性模量和应变回复率。基于热力学测试,选择合适的混合物以制造PDA封堵器的原型,并在装置恢复(从其护套结构),生物降解率和血液相容性等方面评估其体外性能。目前的结果表明,该装置能够在2-3分钟内从护套中弹性恢复以进行部署。该设备会在5-6个月内开始崩解,并且该材料对血液中的血小板和白细胞成分没有不利影响。该设备的生物相容性植入研究表明可接受的组织反应。最后,在猪模型中创建了一个人造PDA导管,并从护套中测试了设备的部署情况:该设备在脱鞘后2-3分钟内恢复,并完全密封了导管,该设备保持稳定并被组织完全覆盖。 1个月的随访。因此,已经开发出完全可降解的用于PDA闭塞的新颖原型,以克服当前使用的金属/织物装置的局限性。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号